Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI). - Shibuki T; Yamashita R; Hashimoto T; Fujisawa T; Imai M; Yuda J; Kuwata T; Misumi T; Nakamura Y; Bando H; Kojima K; Tokioka S; et al. (International journal of clinical oncology, 2026)